课题基金 / 基金详情

ADMINISTRATION OF ROSIGLITAZONE IN PATIENTS WITH SLEEP APNEA

ADMINISTRATION OF ROSIGLITAZONE IN PATIENTS WITH SLEEP APNEA
睡眠呼吸暂停患者服用罗格列酮
批准号：
7378493
负责人：
ALEXANDROS N VGONTZAS
金额：
$10.07万
依托单位：
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-04-01 至 2007-03-31
来源：
https://reporter.nih.gov/project-details/7378493
关键词：
ADMINISTRATIONROSIGLITAZONEPATIENTSSLEEPAPNEA

项目摘要

项目成果

ALEXANDROS N VGONTZAS的其他基金

相似基金

相关文献

中文摘要
翻译
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。本研究的主要假设是，胰岛素抵抗/内脏肥胖是阻塞性睡眠呼吸暂停的发病因素，是其临床严重程度的主要决定因素。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary hypothesis of this study is that insulin resistance/visceral obesity is a pathogenetic factor in obstructive sleep apnea and is a primary determinant of its clinical severity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFECTS OF PARTIAL SLEEP DEP &/OR RECOVERY SLEEP ON SLEEPINESS&CYTOKINE SECRETI
IL-6 SECRETION AND QUANTITY AND QUALITY OF SLEEP: AGE AND GENDER EFFECTS
IL-6 SECRETION AND QUANTITY AND QUALITY OF SLEEP: AGE AND GENDER EFFECTS
EFFECTS OF PARTIAL SLEEP DEP &/OR RECOVERY SLEEP ON SLEEPINESS&CYTOKINE SECRETI
海外基金